Microbot Medical Inc. Reports Board and Executive Changes

Ticker: MBOT · Form: 8-K · Filed: Jan 24, 2025 · CIK: 883975

Microbot Medical Inc. 8-K Filing Summary
FieldDetail
CompanyMicrobot Medical Inc. (MBOT)
Form Type8-K
Filed DateJan 24, 2025
Risk Levelmedium
Pages1
Reading Time2 min
Key Dollar Amounts$0.01, $150,000
Sentimentneutral

Sentiment: neutral

Topics: management-change, compensation

TL;DR

Microbot Medical Inc. shook up its board and exec comp on Jan 17. Big changes incoming?

AI Summary

Microbot Medical Inc. announced on January 17, 2025, changes related to its board of directors and executive compensation. The filing details the departure of certain officers and directors, the election of new directors, and adjustments to compensatory arrangements for key personnel. These changes are effective as of January 17, 2025.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook.

Risk Assessment

Risk Level: medium — Changes in leadership and compensation can indicate internal restructuring or strategic shifts that may carry inherent risks.

Key Players & Entities

  • Microbot Medical Inc. (company) — Registrant
  • January 17, 2025 (date) — Effective date of reported events

FAQ

Who are the specific officers and directors departing from Microbot Medical Inc.?

The filing indicates the departure of certain officers and directors but does not list their specific names in the provided text.

Who are the newly elected directors of Microbot Medical Inc.?

The filing mentions the election of new directors but does not provide their names in the provided text.

What specific changes were made to the compensatory arrangements of certain officers?

The filing states that there were changes to compensatory arrangements but does not detail the specifics of these changes in the provided text.

What is the effective date of these reported changes?

The earliest event reported is dated January 17, 2025, which is also the date of report.

What is the primary business of Microbot Medical Inc.?

Microbot Medical Inc. is in the business of Surgical & Medical Instruments & Apparatus, with SIC code 3841.

Filing Stats: 415 words · 2 min read · ~1 pages · Grade level 12.5 · Accepted 2025-01-24 16:15:31

Key Financial Figures

  • $0.01 — nge on which registered Common Stock, $0.01 par value MBOT NASDAQ Capital Mark
  • $150,000 — hairman, in the amount of approximately $150,000. Item 9.01. Financial Statements and

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MICROBOT MEDICAL INC. By: /s/ Harel Gadot Name: Harel Gadot Title: Chief Executive Officer, President and Chairman Date: January 24, 2025

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.